Nanae Horisawa

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.

Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.

Journal: Journal of medical Internet research

Published: April 09, 2026

Smartphone-Based Acceptance and Commitment Therapy for Postmastectomy Pain Syndrome: A Pilot RCT Evaluating Feasibility, Acceptability, and Preliminary Clinical Outcomes.

Smartphone-Based Acceptance and Commitment Therapy for Postmastectomy Pain Syndrome: A Pilot RCT Evaluating Feasibility, Acceptability, and Preliminary Clinical Outcomes.

Journal: Journal of pain research

Published: November 25, 2025

Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.

Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.

Journal: The breast journal

Published: September 12, 2023

Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X).

Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X).

Journal: Scientific reports

Published: July 29, 2023

Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter.

Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter.

Journal: JMIR formative research

Published: May 31, 2023

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy.

Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy.

Journal: Journal of breast cancer

Published: August 14, 2022

The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.

The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial.

Journal: Annals of surgical oncology

Published: July 26, 2022

Satisfaction survey on a preoperative explanation method using three-dimensional breast imaging for breast cancer patients considering breast-conserving surgery.

Satisfaction survey on a preoperative explanation method using three-dimensional breast imaging for breast cancer patients considering breast-conserving surgery.

Journal: Surgery today

Published: July 06, 2022

Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study.

Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study.

Journal: Anticancer research

Published: May 17, 2022

Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials.

Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials.

Journal: Critical reviews in oncology/hematology

Published: February 03, 2022

Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysis.

Arthralgia induced by endocrine therapy with or without cyclin-dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta-analysis.

Journal: Asia-Pacific journal of clinical oncology

Published: December 07, 2021

Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use.

Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use.

Journal: Journal of breast cancer

Published: November 16, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026